IRIS
SCIOSCIA, CRESCENZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.259
AS - Asia 1.300
EU - Europa 1.101
SA - Sud America 272
AF - Africa 37
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.977
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.204
SG - Singapore 626
CN - Cina 329
SE - Svezia 268
BR - Brasile 238
RU - Federazione Russa 222
HK - Hong Kong 174
DE - Germania 164
FR - Francia 98
GB - Regno Unito 79
FI - Finlandia 74
IT - Italia 71
VN - Vietnam 47
BE - Belgio 39
CA - Canada 36
IN - India 30
UA - Ucraina 20
AR - Argentina 18
CI - Costa d'Avorio 16
PL - Polonia 16
BD - Bangladesh 14
MX - Messico 14
TR - Turchia 13
IR - Iran 12
IQ - Iraq 11
ZA - Sudafrica 11
CZ - Repubblica Ceca 9
ID - Indonesia 9
JP - Giappone 9
NL - Olanda 9
IE - Irlanda 8
AT - Austria 6
ES - Italia 6
LT - Lituania 5
UZ - Uzbekistan 5
AU - Australia 4
PK - Pakistan 4
PY - Paraguay 4
VE - Venezuela 4
CO - Colombia 3
EC - Ecuador 3
EG - Egitto 3
IL - Israele 3
SA - Arabia Saudita 3
AZ - Azerbaigian 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
MA - Marocco 2
PA - Panama 2
SN - Senegal 2
TH - Thailandia 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
HR - Croazia 1
KE - Kenya 1
MN - Mongolia 1
MP - Marianne Settentrionali, isole 1
NP - Nepal 1
PH - Filippine 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 6.977
Salva come PNG Salva come JPEG
Città #
Fairfield 487
Ashburn 458
Chandler 449
Singapore 326
Woodbridge 326
Seattle 269
Houston 265
Ann Arbor 253
Nyköping 227
Cambridge 197
Hong Kong 173
Wilmington 164
Beijing 146
New York 72
Dearborn 68
Munich 63
Lawrence 62
Roxbury 62
Dallas 61
Jacksonville 61
Los Angeles 46
Des Moines 39
Brussels 38
Inglewood 38
Moscow 36
Brooklyn 35
Nanjing 34
Helsinki 28
Paris 28
San Diego 26
Turku 26
Santa Clara 24
Bari 22
Boardman 22
London 21
São Paulo 20
Princeton 19
Ho Chi Minh City 17
Redwood City 17
Abidjan 16
Hebei 16
Warsaw 16
Toronto 15
Buffalo 14
Chicago 10
Denver 10
Stockholm 10
The Dalles 10
Montreal 9
Poplar 9
San Francisco 9
Shenyang 9
Boston 8
Columbus 8
Council Bluffs 8
Dublin 8
Frankfurt am Main 8
Hanoi 8
Shanghai 8
Tokyo 8
Washington 8
Brasília 7
Falkenstein 7
Guangzhou 7
San Mateo 7
Belo Horizonte 6
Chennai 6
Hefei 6
Jiaxing 6
Jinan 6
Johannesburg 6
Kunming 6
Ottawa 6
Amsterdam 5
Ardabil 5
Augusta 5
Brno 5
Campinas 5
Changsha 5
Haiphong 5
Leawood 5
Mexico City 5
Mumbai 5
Rio de Janeiro 5
Ankara 4
Charlotte 4
Da Nang 4
Hangzhou 4
Jakarta 4
Manaus 4
Nanchang 4
New Delhi 4
Nuremberg 4
Querétaro 4
Recife 4
Tashkent 4
Uberlândia 4
Vienna 4
Almenara 3
Atlanta 3
Totale 5.143
Salva come PNG Salva come JPEG
Nome #
AB0836 Drug retention rate of the first tnf inhibitor in radiographic and non radiographic axial spondyloarthritis: data from a multicenter study 163
AB0065 Possible Interplay Between Serum Amyloid-A and Pro-Inflammatory Cytokines Into the Pathogenesis of Behçet's Disease 163
AB0618 A unique ultrasound pattern of adipose tissue in systemic sclerosis patients: a comparison with rheumatoid arthritis patients and healthy controls. two sides of adipose tissue involvement in systemic chronic inflammatory diseases 159
AB0452 Changes in Lipoproteins Associated with Tocilizumab Treatment Do not Influence the Atherogenic Index of Plasma of Rheumatoid Arthritis Patients: Table 1 154
Obesity reduces the drug survival of second line biological drugs following a first TNF-α inhibitor in rheumatoid arthritis patients 151
Two-year survival rates of anti-TNF-α therapy in psoriatic arthritis (PsA) patients with either polyarticular or oligoarticular PsA 145
AB0041 Serum Amyloid A Stimulates The Induction of Inflammatory Mediators in Monocytes from Behçet's Disease Patients: A Proof of Concept Study 144
Refractory knee giant cell tumor of the synovial membrane treated with intra-articular injection of Infliximab: A case series and review of the literature 140
Body mass does not affect the remission of psoriatic arthritis patients on anti-TNF-α therapy 140
SAT0216 Chest Ultrasound Signs of Interstitial Lung Disease in Systemic Sclerosis Patients: A Comparison between High Resolution Chest Computed Tomography Findings 138
AB0369 Adult-onset still’s disease treatment predictors at 1-year follow-up in a single rheumatologic centre experience 137
Leucocytoclastic vasculitis as onset symptom of ulcerative colitis 135
Diffusion and applications of musculoskeletal ultrasound in Italian Rheumatology Units 134
Old and new antirheumatic drugs and the risk of hepatotoxicity 133
A knowledge-based framework enabling decision support in RFID solutions for healthcare 132
Lipid Profile of Rheumatoid Arthritis Patients Treated with Anti-Tumor Necrosis Factor-Alpha Drugs Changes According to Disease Activity and Predicts Clinical Response 131
ANTI-TNFA THERAPY IN PSORIATIC ARTHRITIS: DIFFERENT RATE OF REMISSION IN POLYARTICULAR AND OLIGOARTICULAR SUBSETS 128
Lipids and atherogenic indices fluctuation in rheumatoid arthritis patients on long-term tocilizumab treatment 127
THU0153 The effect of 5-years b-dmards treatment on different 10-years cardiovascular risk scores applied in rheumatoid arthritispatients 125
SAT0212 Pericardial Effusion Related To Systemic Sclerosis: A Possible Contribution of The Serum Levels of Adipokines and Interleukines 124
FRI0110 Methotrexate monotherapy in real life: a drug survival analysis. comparison between very early arthritis and early arthritis cohorts 119
LIPID PROFILE OF RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ANTI-TNF-ALPHA DRUGS CHANGES ACCORDING TO DISEASE ACTIVITY RESPONSE 119
High rate of disease remission in moderate rheumatoid arthritis on etanercept therapy: Data from GISEA, the Italian biologics register 118
Improvement of renal function and disappearance of hepatitis B virus DNA in a patient with rheumatoid arthritis and renal amyloidosis following treatment with infliximab 116
AB1114 Three Years Experience with “Sustain”, an Extra-Hospital Infusion Programme for Patients with Rheumatoid Arthritis Treated with Abatacept 116
AB0245 PREDICTORS OF BIOLOGIC THERAPY DISCONTINUATION IN RHEUMATOID ARTHRITIS PATIENTS AFTER REMISSION ACHIEVEMENT: A MONOCENTRIC OBSERVATIONAL STUDY FROM BIOLOGIC APULIAN REGISTRY (BIOPURE) 110
Evaluation of Serum Levels of Adipokines and Interleukines in Pericardial Effusion Related to Systemic Sclerosis 109
OP0129 Drug survival on anti-tnf-alpha in psoriatic arthritis patients with axial involvement and analysis of predictors 108
Different joint and skin clinical response of patients with psoriatic arthritis treated with infliximab 107
Serum cartilage oligomeric matrix protein (COMP) following infliximab treatment in patients with rheumatoid arthritis: Analitical performances and clinical correlations 102
null 101
Response of cartilage oligomeric matrix protein to monoclonal antibody drugs in patients with rheumatoid arthritis 101
THU0168 Relationships between body fat composition assessed with bioelectrical impedance analysis, serum adipokines and disease activity in patients with rheumatoid arthritis 100
Intentional etanercept use during pregnancy for maintenance of remission in rheumatoid arthritis 99
Giant Cell Tumor of Synovial Sheath: Of Two Cases Treated with Intra-Articular Infiltration of Infliximab 98
null 97
Ultrasonography in the diagnosis and management of patients with inflammatory arthritides 97
SAT0380 FIBROMYALGIA IS THE STRONGEST NEGATIVE PREDICTOR FOR THE ACHIEVEMENT OF EITHER REMISSION AND MINIMAL DISEASE ACTIVITY IN NAIVE PSORIATIC ARTHRITIS PATIENTS STARTING BIOLOGIC DRUGS 95
The italian MSUS study group recommendations for the format and content of the report and documentation in musculoskeletal ultrasonography in rheumatology 93
Drug survival and effectiveness of ustekinumab in patients with psoriatic arthritis. Real-life data from the biologic Apulian registry (BIOPURE) 90
Infliximab therapy in patients with rheumatic disease and HCV chronic infection 88
SAT0061 Concurrent Ultrasound-Detected Synovitis and Tenosynovitis Predict Flare in Patients with Rheumatoid Arthritis in Clinical Remission 87
OP0217 Ultrasound-Detected Synovitis and Tenosynovitis Independently Associate with Flare in Patients with Rheumatoid Arthritis in Clinical Remission 87
null 84
Osteocalcin production by osteoarthritic osteoblasts after vitamin D stimulation 84
null 82
null 82
Integrin expression on human osteoblasts in osteoarthritis 82
COMP serum levels in patients with rheumatoid arthritis before and after infliximab therapy 81
null 79
The treatment of recurrent uveitis with TNF-alpha inhibitors 74
null 73
Increased Bcl-2/p53 ratio in human articular cartilage: a possible role in regulation of chondrocyte metabolism 72
Leukocytoclastic vasculitis as onset symptom of ulcerative colitis 69
null 66
Evidence-based algorithm for diagnosis and assessment in psoriatic arthritis: Results by Italian DELphi in psoriatic arthritis (IDEA) 66
Economical Evaluation of the Sustain Program for the Out-of-Hospital Administration of Abatacept for Rheumatoid Arthritis 64
Correction to: Drug survival and effectiveness of ustekinumab in patients with psoriatic arthritis. Real-life data from the biologic Apulian registry (BIOPURE) (Clinical Rheumatology, (2018), 37, 3, (667-675), 10.1007/s10067-018-3989-2) 63
Ultrasonography in psoriatic arthritis: Which sites should we scan? 62
Effective tumour necrosis factor-blocking therapy reduces reactive oxygen metabolite level in rheumatoid arthritis 61
Plasma pentraxin 3 in idiopathic inflammatory myopathies: a possible new biomarker of disease activity 60
Musculoskeletal ultrasonography for psoriatic arthritis and psoriasis patients: A systematic literature review 58
Ultrasound-Detected Tenosynovitis Independently Associates with Flare in Patients with Rheumatoid Arthritis in Clinical Remission 56
Use of etanercept in the treatment of dermatomyositis: a case series 55
null 53
Non-Adherence to Disease-Modifying Anti-Rheumatic Drugs in Patients with Rheumatoid Arthritis: An Italian Survey 49
L'obésité diminue le maintien thérapeutique des traitements biologiques de seconde ligne après échec d'un anti-TNF de première ligne au cours de la polyarthrite rhumatoïde 48
null 46
null 45
null 44
Influence of TNF- α inhibition on oxidative stress of rheumatoid arthritis patients 43
Repeated infusions of low-dose infliximab plus methotrexate in psoriathic arthrtritis: immediate benefitis are not maintained after discontinuation of inlfiximab 41
Use of ultrasound in treatment decisions for patients with rheumatoid arthritis: an observational study in Italy 38
Ultrasound-detected tenosynovitis independently associates with patient-reported flare in patients with rheumatoid arthritis in clinical remission: Results from the observational study STARTER of the Italian Society for Rheumatology 38
The predictive role of ultrasound-detected tenosynovitis and joint synovitis for flare in patients with rheumatoid arthritis in stable remission. Results of an Italian multicentre study of the Italian Society for Rheumatology Group for Ultrasound: The STARTER study 32
Power Doppler signal at the enthesis and bone erosions are the most discriminative OMERACT ultrasound lesions for SpA: results from the DEUS (Defining Enthesitis on Ultrasound in Spondyloarthritis) multicentre study 16
Turning the Tide against Herpes Zoster in Rheumatoid Arthritis Patients Treated with JAK Inhibitors 3
Totale 7.129
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.255
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.255
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021442 0 0 0 0 0 26 91 102 43 79 60 41
2021/2022537 39 41 8 25 26 40 15 23 24 44 79 173
2022/20231.034 114 150 82 116 113 130 29 108 144 10 23 15
2023/2024252 18 57 15 22 19 59 4 13 4 8 2 31
2024/20251.250 24 21 101 44 12 100 120 167 54 78 198 331
2025/20261.316 398 114 124 247 374 59 0 0 0 0 0 0
Totale 7.129